Elite Pharmaceuticals Inc
ELTP· OTC
Released Feb 14, 2022, after the close
10-Q filed Feb 14, 2022, 45 days after period end · 0001493152-22-004471
| Metric | Q3 2022 | Q3 2021 | Q3 2020 | Q3 2019 |
|---|---|---|---|---|
| Revenue | $8.97M | $6.05M | $5.06M | $2.69M |
| Net Income | $2.28M | $2.01M | -$1.86M | -$2.34M |
| EPS Diluted |
Elite Pharmaceuticals Inc · CIK 1053369 · Engraved from SEC EDGAR
| $0.00 |
| $0.00 |
| $0.00 |
| $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.